Fact-checked by Grok 2 weeks ago

PMSF

Phenylmethylsulfonyl fluoride (PMSF) is a small-molecule organofluorine widely used as an irreversible inhibitor of serine proteases in biochemical research. It functions by covalently modifying the active-site serine residue through sulfonylation, thereby blocking the enzymatic activity of proteases such as , , . This inhibition prevents unwanted protein degradation during the preparation of cell lysates and extraction procedures, making PMSF a staple in protocols for studying proteins and enzymes. PMSF is typically supplied as a white crystalline powder with the C₇H₇FO₂S and a molecular weight of 174.19 g/, and it is soluble in solvents like , isopropanol, and (DMSO), though it hydrolyzes rapidly in aqueous solutions with a of about 110 minutes at 7 and 25°C. Due to its instability in water, it is commonly added fresh to buffers at concentrations of 0.1–1 mM just before use. While effective against serine hydrolases, PMSF does not inhibit other classes like or metalloproteases, so it is often combined with additional inhibitors in comprehensive cocktails for broad-spectrum protection. Beyond its primary role in protein stabilization, PMSF has been employed in studies of mechanisms and as a tool in to map active sites, though its toxicity—manifesting as and irritation upon exposure—requires careful handling under protocols. First synthesized in the mid-20th century, PMSF remains a cost-effective and reliable reagent in , with ongoing relevance in fields like and .

Overview

Chemical Identity and Nomenclature

Phenylmethylsulfonyl fluoride, commonly abbreviated as PMSF, is an sulfonyl identified by the molecular formula C₇H₇FO₂S and a molecular weight of 174.19 g/mol. Its systematic IUPAC name is (phenylmethyl)sulfonyl , reflecting the sulfonyl group attached to a phenylmethyl . The compound is registered under CAS number 329-98-6 in chemical databases. Common synonyms for PMSF include phenylmethanesulfonyl fluoride and benzylsulfonyl fluoride. Structurally, PMSF features a benzene ring directly attached to a methylene group (CH₂), which is bonded to a sulfonyl fluoride functional group (SO₂F), giving it the linear chain representation C₆H₅CH₂SO₂F.

Historical Background

Phenylmethanesulfonyl fluoride (PMSF), a sulfonyl fluoride derivative, emerged in during the mid- as part of broader explorations into organofluorine compounds for chemical reactivity. Sulfonyl fluorides in general were first synthesized in the early , but PMSF's specific preparation and description as a gained attention in the 1950s through synthetic routes involving sulfonyl chloride fluorination. These early efforts positioned sulfonyl fluorides, including PMSF, as versatile derivatives for introducing sulfonyl groups into molecules. Initially, PMSF found use in during the 1960s as a sulfonylating agent, capitalizing on its reactivity toward nucleophiles like amines and alcohols to form sulfonamides and esters. This application preceded its recognition in biochemistry, where it served as a for modifying functional groups under mild conditions, distinct from more reactive sulfonyl chlorides. By the mid-1960s, researchers began investigating its potential beyond synthetic utility, leading to pivotal studies on interactions. A landmark contribution came from the work of David E. Fahrney and Allen M. Gold, who in 1963 demonstrated that sulfonyl fluorides, including PMSF, act as potent irreversible inhibitors of serine esterases such as α-chymotrypsin, , and . Their study quantified reaction rates, showing PMSF's sulfonylation of the active-site serine residue, which established its specificity and mechanism as a covalent modifier. A follow-up 1964 publication by the same authors detailed the formation and stability of phenylmethanesulfonyl-α-chymotrypsin, confirming the irreversible nature of the inhibition and its implications for enzyme studies. By the , PMSF had evolved from a niche to a inhibitor in biochemical protocols, routinely added to cell lysates to prevent proteolytic degradation during and analysis. This widespread adoption stemmed from its efficacy against key serine proteases like and , as evidenced in seminal applications for isolating enzymes and studying cellular extracts. High-impact reviews and protocols from the era solidified its role, influencing countless studies in enzymology and .

Chemical Properties

Physical and Spectroscopic Properties

PMSF is a white to off-white crystalline solid. Its melting point ranges from 92 to 95 °C. The compound has a density of 1.3 g/cm³. PMSF decomposes before reaching its boiling point at atmospheric pressure, but it boils at approximately 112 °C under reduced pressure (16 mm Hg). It is insoluble in water but exhibits good solubility in various organic solvents, including ethanol, DMSO, and isopropanol; for example, it dissolves up to 200 mM in anhydrous isopropanol. The (IR) spectrum of PMSF features characteristic sulfonyl (S=O) stretching vibrations at 1350–1380 cm⁻¹ (asymmetric) and 1170–1190 cm⁻¹ (symmetric), consistent with sulfonyl fluoride functional groups. In the ¹H NMR spectrum (recorded in CDCl₃), the phenyl protons appear as a multiplet at 7.3–7.5 , while the methylene protons resonate at approximately 4.7 (with coupling to ¹⁹F observed). The ¹⁹F NMR for the sulfonyl fluoride fluorine is reported at +66.3 (relative to CFCl₃ in CDCl₃).

Reactivity and Stability

Phenylmethanesulfonyl fluoride (PMSF) exhibits high reactivity as an , primarily due to its sulfonyl fluoride , which is highly susceptible to nucleophilic attack by , ions, or nucleophilic residues in biological systems. This reactivity underpins its role as a covalent modifier, but it also contributes to its instability in protic environments. The sulfonyl fluoride moiety undergoes , where the serves as a good , facilitating rapid reaction kinetics. The primary degradation pathway for PMSF is , which proceeds via nucleophilic attack on the atom of the sulfonyl group, leading to the release of and formation of phenylmethanesulfonic . In aqueous solutions, this decomposition is rapid, with half-lives ranging from approximately 110 minutes at 7.0 to 35 minutes at 8.0 (at 25°C), and the rate accelerates under more basic conditions due to increased concentration. PMSF displays greater stability in acidic environments ( <5), where is significantly slowed, allowing for longer retention of activity compared to or alkaline conditions. In non-aqueous solvents, PMSF demonstrates substantially improved , remaining active for months when stored as a 100–200 mM in isopropanol or DMSO at -20°C or 2–8°C. These conditions minimize nucleophilic attack, preserving the integrity of the sulfonyl fluoride group. However, PMSF is sensitive to environmental factors that promote degradation: prolonged exposure to air should be avoided to prevent moisture-induced . Additionally, should be protected from light to maintain long-term .

Synthesis

Laboratory Preparation

Phenylmethanesulfonyl fluoride (PMSF) is commonly prepared in the laboratory via a nucleophilic halide exchange reaction between benzylsulfonyl chloride and a fluoride salt, such as potassium fluoride (KF) or sodium fluoride (NaF), in a polar aprotic solvent like acetonitrile. This method leverages the higher nucleophilicity of fluoride ions to displace the chloride, forming the sulfonyl fluoride product. Originally synthesized in 1963 by Fahrney and Gold using a similar halide exchange approach. An alternative laboratory approach involves the deoxyfluorination of benzylsulfonic acid derivatives, such as benzylsulfonamides, using (DAST) as the fluorinating agent. reacts with the to introduce the atom, yielding the sulfonyl after . Both methods are typically conducted at or with mild heating (up to 50–80°C) under an inert atmosphere, such as or , to prevent by atmospheric moisture, which can degrade the moisture-sensitive reagents and product. Reaction times vary from 1–24 hours depending on the scale and conditions, with small-scale preparations (e.g., 1–10 g) being straightforward for research settings. Following the reaction, PMSF is purified by recrystallization from or, for higher purity, by using hexane-ethyl acetate eluents, achieving isolated yields of 70–90%. involving fluoride sources like or NaF requires performing the reaction in a well-ventilated , as trace amounts of (HF) may be generated during the exchange, posing risks of and . DAST handling also demands caution due to its and potential to release HF upon or contact with moisture.

Industrial Production

Commercial production of phenylmethylsulfonyl fluoride (PMSF) is not publicly detailed but likely follows routes analogous to laboratory synthesis, such as halide exchange reactions with fluoride sources. Key manufacturers include MilliporeSigma (formerly Sigma-Aldrich), Thermo Fisher Scientific, and Enzo Life Sciences, which supply PMSF globally for research and biochemical applications. PMSF is typically supplied as a crystalline powder with purity standards of ≥98.5% as determined by (GC), or in pre-dissolved form in solvents like isopropanol or DMSO for ease of use. Due to its niche role as a , PMSF is generally produced rather than in massive bulk, with costs ranging from approximately $50–100 per gram for small quantities (e.g., 1–5 g packs) to $15–20 per gram for larger orders (10–50 g) as of 2025. As a hazardous substance, PMSF is regulated under chemical rules, classified as UN 2928 (Toxic solid, corrosive, organic, n.o.s., phenylmethylsulfonyl fluoride), requiring special , labeling, and for shipping to prevent risks.

Biochemical Mechanism

Inhibition of Serine Proteases

PMSF functions as an irreversible inhibitor of serine proteases by covalently modifying the nucleophilic hydroxyl group of the serine residue. The inhibition proceeds via a nucleophilic attack by the serine hydroxyl on the electrophilic sulfur atom of the sulfonyl fluoride group in PMSF, displacing the and forming a stable sulfonyl-enzyme . This prevents the from catalyzing peptide or bond , effectively inactivating it. The reaction can be depicted as follows: \text{Enzyme-Ser-OH} + \ce{C6H5CH2SO2F} \rightarrow \text{Enzyme-Ser-O-SO2CH2C6H5} + \ce{[HF](/page/HF)} The inhibition are second-order, with the rate depending on both and concentrations, and exhibit stoichiometric binding in a 1:1 molar ratio. For α-chymotrypsin, the second-order rate constant is approximately 250 M⁻¹ s⁻¹, corresponding to a of inhibition of about 2.8 seconds at 1 mM PMSF concentration. Structural studies using have confirmed the sulfonylation of the active site serine in inhibited serine proteases. For instance, the atomic-resolution structure of covalently bound to PMSF reveals the sulfonyl group attached to Ser195, stabilizing the and blocking the . PMSF demonstrates broad inhibitory activity against serine hydrolases, extending beyond endopeptidases to include esterases such as , due to the conserved nucleophilic serine mechanism across these enzyme classes.

Specificity and Limitations

Phenylmethylsulfonyl fluoride (PMSF) is highly effective against a range of serine proteases that possess accessible active site serine residues, including , , , and . These enzymes are irreversibly inhibited through sulfonylation of the catalytic serine, preventing proteolytic activity during protein extraction and analysis. However, PMSF exhibits limitations in its target range, showing no activity against proteases, aspartic proteases, or metalloproteases, as its relies specifically on the nucleophilic attack by serine hydroxyl groups rather than other catalytic residues. Additionally, certain serine proteases, such as palmitoyl-protein thioesterase 1 (PPT1), are insensitive to PMSF due to structural constraints in their active sites that hinder inhibitor access or reactivity. Beyond its intended targets, PMSF displays off-target effects by inhibiting non-protease serine hydrolases, notably , through the same sulfonylation mechanism. This broad reactivity can interfere with unrelated enzymatic processes in complex biological samples. Key limitations of PMSF include its short in aqueous buffers, approximately 110 minutes at pH 7 and 25°C, which restricts its duration of action and necessitates fresh preparation for each use. It also exhibits poor cell permeability, making it unsuitable for inhibiting intracellular proteases in live cells and limiting its application to cell lysates or in vitro assays. Furthermore, PMSF poses toxicity concerns as a potent , requiring careful handling to avoid systemic exposure. Compared to alternatives like 4-(2-aminoethyl)benzenesulfonyl (AEBSF), PMSF is less specific, as it can also inhibit some proteases, but it remains cheaper and acts more rapidly on sensitive targets.

Applications

In Protein and Purification

PMSF is commonly added to lysis buffers during protein extraction at final concentrations of 0.1–1 mM to inhibit serine proteases and prevent unwanted of target proteins following . Stock solutions of PMSF are typically prepared at 100–200 mM in anhydrous solvents such as isopropanol or DMSO, as it is insoluble in aqueous buffers, and these stocks should be added fresh to the immediately before use due to its short in water (approximately 110 minutes at 7 and 25°C). In biochemical workflows, PMSF is integrated into for , where it is added to cell lysates to maintain protein integrity during antibody binding and bead capture; Western blotting, to preserve sample quality prior to ; and enzyme assays, to avoid degradation of active enzymes during incubation. It is often combined with other inhibitors, such as (a broad-spectrum inhibitor), to provide comprehensive protection against multiple protease classes in the lysate. The effectiveness of PMSF is evident in its ability to reduce degradation of sensitive proteins, such as kinases and receptors, in mammalian lysates, thereby yielding higher yields and better preservation of post-translational modifications like . For instance, in mammalian tissue homogenization protocols, tissues are often resuspended in () containing 1 mM PMSF and mild detergents like 0.1–1% , followed by mechanical disruption (e.g., using a ) on to extract soluble proteins while minimizing proteolytic activity.

Other Uses

Beyond its primary role in protein extraction, phenylmethylsulfonyl fluoride (PMSF) finds applications in research, particularly in studies of organophosphate-induced delayed neuropathy (OPIDN). In these investigations, PMSF pretreatment inhibits neuropathy target (NTE), a key targeted by , thereby protecting against degradation and the onset of neuropathic symptoms in animal models such as hens and rats exposed to compounds like triorthocresyl (TOCP) or mipafox. This protective effect highlights PMSF's utility in elucidating the mechanisms of , where timely administration can prevent neurological damage without inducing toxicity itself. In dental research, PMSF serves as a source of fluoride for enamel remineralization studies. When exposed to salivary proteases, PMSF undergoes enzymatic cleavage that releases fluoride ions, which enhance surface hardness recovery and fluoride uptake in demineralized enamel slabs more effectively than sodium fluoride solutions alone. This application leverages PMSF's hydrolysis to deliver localized fluoride, promoting remineralization in vitro models of early caries lesions. PMSF also functions as a sulfonylating agent in , particularly within sulfur(VI) fluoride exchange (SuFEx) frameworks. As a benzylsulfonyl fluoride, it reacts efficiently with nucleophiles such as amines to form sulfonamides or with alcohols under catalytic conditions to yield sulfonate esters, enabling the construction of diverse sulfur-containing motifs in and . This reactivity stems from the labile leaving group, allowing selective bond formation in late-stage functionalization of complex molecules. In toxicology studies, PMSF is employed to modulate cholinesterase inhibition in pesticide research. By irreversibly sulfonylating the active site serine of acetylcholinesterase (AChE), PMSF blocks or potentiates the effects of organophosphate pesticides like chlorpyrifos, aiding in the assessment of cumulative exposure risks and neurotoxic potential in vitro and in vivo. This approach helps differentiate acute cholinergic toxicity from delayed neuropathy, with PMSF dosing strategies revealing compound-specific interactions in models of pesticide poisoning. An emerging application of PMSF lies in , where it supports activity-based protein profiling (ABPP) of serine . As a broad-spectrum , PMSF is used to confirm probe specificity in ABPP workflows by quenching serine signals, enabling the identification and quantification of active enzymes in complex proteomes such as those from lung adenocarcinoma tissues. This facilitates the distinction between catalytically active and inhibited , advancing functional annotation in disease-related studies.

Handling and Safety

Storage and Stability in Solutions

PMSF, supplied as a white crystalline powder, is hygroscopic and must be stored in a tightly sealed, desiccated to prevent moisture absorption and degradation. For optimal long-term stability, it should be kept at -20 °C, where it remains active for 1–2 years. Stock solutions of PMSF should be prepared fresh in solvents such as 100% or isopropanol at concentrations of 100–200 mM, as the compound undergoes rapid in aqueous environments. These stocks are stable for several months at -20 °C or up to 9 months at 2–8 °C, and storing them in aliquots minimizes freeze-thaw cycles that could compromise activity. In 100% at 4 °C, PMSF maintains stability for weeks. PMSF should be added directly to experimental buffers immediately before use to preserve efficacy. In aqueous solutions, PMSF degrades primarily through of the sulfonyl fluoride group, with stability decreasing at higher and temperature; half-lives are approximately 110 minutes at 7.0, 55 minutes at 7.5, and 35 minutes at 8.0 (all at 25 °C). Factors accelerating degradation include exposure to , basic conditions, and , which should be avoided during handling and storage. Loss of activity can be monitored via residual inhibition assays, which measure the compound's ability to suppress function.

Toxicity and Precautions

Phenylmethylsulfonyl fluoride (PMSF) exhibits primarily through its action as a potent inhibitor of cholinesterases, including , leading to symptoms such as , , convulsions, and potentially upon significant exposure. The oral LD50 in mice is approximately 200 mg/kg, indicating moderate via ingestion, while intraperitoneal administration in rats yields an LD50 of 150 mg/kg. Exposure routes include , which can be fatal due to rapid absorption and systemic effects (GHS H330), dermal contact causing toxicity through skin absorption (GHS H311), and ocular or respiratory irritation leading to burns and . PMSF is also a strong irritant to eyes and mucous membranes, with potential for severe damage upon direct contact. Under the Globally Harmonized System (GHS), PMSF is classified as acutely toxic (H301 for oral, H311 for dermal, H331 for ) and corrosive (H314 for and eye damage). Safety precautions emphasize handling PMSF exclusively in a chemical to minimize risks, while wearing appropriate (PPE) such as nitrile gloves, safety goggles, lab coat, and respiratory protection if dust or aerosols are generated. of spills or contaminated surfaces should involve a 5% (Na2CO3) solution to neutralize the compound, followed by thorough rinsing with . For first aid, immediately wash exposures with and for at least 15 minutes; flush eyes with for 15 minutes and seek ophthalmologic evaluation; for , move to fresh air and administer oxygen if needed; and for ingestion, do not induce vomiting but provide or milk and seek immediate medical attention, as no specific antidote exists—treatment focuses on symptomatic relief and monitoring for from fluoride release.

References

  1. [1]
    Phenylmethylsulfonyl Fluoride | C7H7FO2S | CID 4784 - PubChem
    Phenylmethanesulfonyl fluoride is an acyl fluoride with phenylmethanesulfonyl as the acyl group. It has a role as a serine proteinase inhibitor.
  2. [2]
  3. [3]
  4. [4]
    PMSF Protease Inhibitor 5 g | Buy Online - Thermo Fisher Scientific
    6–10 day deliveryPMSF Protease Inhibitor. Thermo Scientific PMSF is a protease inhibitor that reacts with serine residues to inhibit trypsin, chymotrypsin, thrombin and ...PMSF Protease Inhibitor · Inhibiteur de protéases PMSF · 36978
  5. [5]
    PMSF – Serine Protease Inhibitor - APExBIO
    Free 365-day returnsPMSF (Phenylmethylsulfonyl fluoride) is an irreversible serine protease inhibitor widely used to block protein degradation in biochemical research.Missing: What | Show results with:What<|control11|><|separator|>
  6. [6]
    Benzylsulfonyl Fluoride - an overview | ScienceDirect Topics
    Phenylmethylsulfonyl fluoride (PMSF) is a covalent inhibitor of serine hydrolases commonly used in the preparation of cell lysates (Le et al., 2015). It has ...
  7. [7]
  8. [8]
  9. [9]
  10. [10]
    PMSF Phenylmethylsulfonyl fluoride 329-98-6
    ### Summary of PMSF from https://www.sigmaaldrich.com/US/en/product/roche/pmsfro
  11. [11]
    CAS RN 329-98-6 - Fisher Scientific
    CAS RN 329-98-6. IUPAC Name: phenylmethanesulfonyl fluoride. Synonyms: phenylmethylsulfonyl fluoride PMSF. Molecular Weight (g/mol): 174.19. Molecular Formula: ...
  12. [12]
    Sulfur(vi) fluorides as tools in biomolecular and medicinal chemistry
    Starting from the synthesis of the first organic S(vi) fluorides in the 1920–1930s and then additional work by Fahrney and Gold in the 1960s, the utility ...
  13. [13]
    [83] Sulfonylation with sulfonyl halides - ScienceDirect
    The sulfonylating agents are aromatic and aliphatic sulfonyl chlorides and fluorides. ... sulfonyl; PMS, phenylmethanesulfonyl (α-toluenesulfonyl); PMSF ... (1960) ...
  14. [14]
    Sulfonyl Fluorides as Inhibitors of Esterases. I. Rates of Reaction ...
    Sulfonyl Fluorides as Inhibitors of Esterases. I. Rates of Reaction with Acetylcholinesterase, α-Chymotrypsin, and Trypsin.
  15. [15]
    Sulfonyl Fluorides as Inhibitors of Esterases. II. Formation and Reactions of Phenylmethanesulfonyl α-Chymotrypsin*
    ### Summary of Phenylmethanesulfonyl α-Chymotrypsin Formation and Reactions, and PMSF Context
  16. [16]
    Sulfonyl fluorides as privileged warheads in chemical biology - NIH
    Mar 16, 2015 · Fahrney and Gold were the first to develop sulfonyl fluoride (SF) inhibitors of serine proteases. · Beyond the commercially available reagents ...Missing: history | Show results with:history
  17. [17]
    None
    ### Summary of PMSF Properties from P7626pis-ms.pdf
  18. [18]
    Phenylmethanesulfonyl fluoride ≥98.5 (GC) PMSF
    ### Summary of PMSF Storage, Stability, and Handling (Product P7626)
  19. [19]
    Sulfur(VI) fluorides as tools in biomolecular and medicinal chemistry
    Jan 20, 2023 · This review aims to serve as a primer highlighting synthetic strategies toward a diversity of S(VI) fluorides and their application in chemical biology, ...<|separator|>
  20. [20]
    Mild and Efficient Synthesis of Sulfonyl Fluorides from Sulfonamides ...
    The commercially available fluorinating agent diethylaminosulfur trifluoride (DAST) is used to efficiently transform structurally diverse secondary sulfonamides ...
  21. [21]
    Sulfonyl Fluoride Synthesis through Electrochemical Oxidative ...
    Jul 13, 2019 · We report a mild and environmentally benign electrochemical approach to prepare sulfonyl fluorides using thiols or disulfides, as widely available starting ...
  22. [22]
    Phenylmethylsulfonyl fluoride | 329-98-6 - ChemicalBook
    In biochemistry, Phenylmethylsulfonyl fluoride (PMSF) is a serine protease inhibitor commonly used in preparation of cell lysates. It is rapidly degraded in ...Missing: IUPAC | Show results with:IUPAC
  23. [23]
    Facile one-pot synthesis of sulfonyl fluorides from sulfonates or ...
    May 7, 2019 · This new protocol features mild reaction conditions using readily available and easy-to-operate reagents. A diverse set of sulfonyl fluorides ...
  24. [24]
    Phenylmethylsulfonyl fluoride - Enzo
    27, 2693 (1978), Abstract; Inactivation of the protease inhibitor phenylmethylsulfonyl fluoride in buffers: G.T. James; Anal. Biochem. 86, 574 (1978), Abstract ...<|control11|><|separator|>
  25. [25]
    Phenylmethanesulfonyl fluoride, 99% 1 g - Thermo Fisher Scientific
    In stock $86 deliveryPhenylmethanesulfonyl fluoride, 99% ; Catalog number 215740010 ; Price (USD). 56.65. Special offer. Online exclusive. Ends: 31-Dec-2025. 66.30. Save 9.65 (15%).<|control11|><|separator|>
  26. [26]
  27. [27]
    [PDF] Safety Data Sheet - Cayman Chemical
    Aug 12, 2023 · Decomposition temperature: Not determined. · Ignition temperature: Not determined. · Danger of explosion: Product does not present an ...
  28. [28]
  29. [29]
    Small-molecule inhibitor: PMSF - MEROPS - the Peptidase Database
    Sep 8, 2023 · Sulfonyl fluorides were discovered as inhibitors of serine peptidases by Fahrney & Gold (1963). Peptidases inhibited: PMSF inhibits serine ...
  30. [30]
  31. [31]
    Addition of phenylmethylsulfonyl fluoride increases the working ...
    Addition of 10 μM PMSF to the mixture resulted in significantly higher rates of PHEN clearance in 2 h incubations relative to those obtained in the absence of ...
  32. [32]
  33. [33]
    PMSF Solution (0.1 M) - Boston BioProducts
    It does not inhibit metalloproteases, cysteine proteases, or aspartic proteases. PMSF solution can be added to lysis and extraction buffers to support ...Missing: ineffective | Show results with:ineffective
  34. [34]
    Inactivation studies of acetylcholinesterase with ... - PubMed
    Acetylcholinesterase (AChE), a serine hydrolase, is potentially susceptible to inactivation by phenylmethylsulfonyl fluoride (PMSF) and benzenesulfonyl ...Missing: off- target
  35. [35]
    PMSF | Additional Synthetic Protease Inhibitors - R&D Systems
    $$45 deliveryThe effect of the enzyme inhibitor phenylmethylsulfonyl fluoride on the pharmacological effect of anandamide in the mouse model of cannabimimetic activity.<|control11|><|separator|>
  36. [36]
  37. [37]
  38. [38]
    Protein and antibody purification followed by immunoprecipitation of ...
    Jun 7, 2022 · Note: The final volume (antibody + 1× PBS + 1 mM PMSF) should be 200 μL per 50 μL of Dynabeads. ... Store stock solution of sodium dodecyl ...
  39. [39]
    Protease and Phosphatase Inhibitors | Thermo Fisher Scientific - US
    ... PMSF Protease Inhibitor, Each. 105.65. Online Exclusive. 117.00. Save 11.35 ... Price & Freight Policy. Cookie Preferences. Your choices regarding cookies on ...
  40. [40]
  41. [41]
    [PDF] Active Site Inhibitors Protect Protein Kinase C from ... - Newton Lab
    Taken together, these data reveal that active site inhibitors prevent the dephosphorylation and subsequent degradation of endogenous, conventional PKC α as well ...
  42. [42]
    Differential detergent fractionation of membrane protein from ... - NIH
    The tissue was washed twice in 2 mL ice cold PBS fortified with 1mM PMSF and centrifuged at 100 × g for 2 min. It was then homogenized in a dounce homogenizer ...
  43. [43]
    [PDF] Recombinant Protein Purification
    Selection of an extraction technique depends as much on the equipment available and ... Techniques for protein purification. Protein property.
  44. [44]
    Phenylmethylsulfonyl fluoride protects against the degradation of ...
    These results demonstrated the pretreatment with PMSF could inhibit TOCP-induced NF degradation while it protected hens against the development of OPIDN.Missing: neuroscience | Show results with:neuroscience
  45. [45]
    Phenylmethylsulfonyl fluoride protects rats from Mipafox-induced ...
    These data indicate that PMSF pretreatment protects rats against Mipafox-induced neurological damage and that the timing of administration and order of ...Missing: neuroscience organophosphate
  46. [46]
    Phenylmethylsulfonyl fluoride, a potentiator of neuropathy, alters the ...
    Nov 19, 2012 · The estimated constant of the chemical hydrolysis of PMSF was kh = 0.23 min(-1). Eα, which is sensitive to mipafox and resistant to PMSF ...Missing: half- life stability<|control11|><|separator|>
  47. [47]
    [PDF] Effect of phenylmethylsulfonyl fluoride, a protease inhibitor ... - SciELO
    Sep 9, 2022 · Aim: to evaluate if fluoride released by salivary protease action on PMSF affects enamel remineralization and fluoride uptake. Methods: Groups ...
  48. [48]
    Effect of phenylmethylsulfonyl fluoride, a protease inhibitor, on ...
    Fluoride released from PMSF was more effective in enhancing %SHR and increasing fluoride uptake in enamel compared with SHS alone (p < 0.05); furthermore, it ...Missing: HF hydrolysis
  49. [49]
  50. [50]
    and acetylcholine-hydrolyzing activities in chicken brain
    PMSF (phenylmethylsulfonyl fluoride) is a non-inducer NTE inhibitor that protects neuropathy development when dosed before a neuropathic dose of a ...Missing: research | Show results with:research
  51. [51]
    Depletion-dependent activity-based protein profiling using SWATH ...
    May 27, 2025 · We demonstrate the utility of the method in advanced lung adenocarcinoma (LUAD) by monitoring nearly 4000 protein groups and 200 serine hydrolases (SHs) in ...
  52. [52]
    Activity-based protein profiling: The serine hydrolases - PMC - NIH
    Without an activity-based probe like FP-biotin, standard genomics and/or proteomics studies would have difficulty distinguishing free (active) from inhibitor- ...Missing: PMSF | Show results with:PMSF
  53. [53]
    [PDF] Technical Data Sheet - BioPioneer
    Storage Conditions: Store PMSF at -20°C in a tightly sealed container to prevent moisture absorption and degradation. Avoid prolonged exposure to light, air ...
  54. [54]
    Specificity of the serine protease inhibitor, phenylmethylsulfonyl ...
    Aug 9, 2025 · In marine invertebrates, the differential inhibition of PMSF and TLCK has been used to differentiate the digestive activity of chymotrypsin and ...
  55. [55]
    [PDF] Common Stock Solutions, Buffers, and Media - Heyer Lab
    Make fresh dilutions from the alcohol stock for each use, because the half-life of PMSF in aqueous solution is <30 min at room temperature and a few hours ...
  56. [56]
    None
    ### Physical Properties of PMSF (Phenylmethanesulfonyl fluoride)
  57. [57]
    Phenylmethylsulfonyl fluoride inhibitory effects on ...
    ... fluoride (PMSF) suggested that PMSF might preferentially inhibit different AChE ... inhibit 80% of brain AChE without causing peripheral cholinergic toxicity.
  58. [58]
    [PDF] SOP for the safe use of Phenylmethylsulfonyl Fluoride (PMSF) Date
    Phenylmethylsulfonyl Fluoride (PMSF) (CAS#: 329-98-6) is a solid with a melting point of 92 degree Celsius. In biochemistry, PMSF is a serine protease ...Missing: decomposition temperature